DURECT Corp (NASDAQ:DRRX)
| 1.87 Delayed Data As of Oct 20 |  +0.06 / +3.31%Today’s Change | 0.95 Today|||52-Week Range 3.95 | -50.79% Year-to-Date |
Latest DRRX News | Press Releases
No recent news for DURECT Corp.
Today’s Trading
| Previous close | 1.81 |
| Today’s open | 1.85 |
| Day’s range | 1.81 - 1.87 |
| Volume | 482,343 |
| Average volume (3 months) | 1,440,890 |
| Market cap | $373.1M |
Data as of 3:59pm ET, 10/20/2020
Growth & Valuation
| Earnings growth (last year) | +27.02% |
| Earnings growth (this year) | +45.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +59.25% |
| P/E ratio | NM |
| Price/Sales | 22.88 |
| Price/Book | 15.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBYIPuma Biotechnology I... | -0.29 | -3.03% |
| XENEXenon Pharmaceutical... | -0.13 | -1.20% |
| --China Health Group I... | -0.02 | -5.06% |
| OSMTOsmotica Pharmaceuti... | -0.12 | -2.01% |
Data as of 10/21/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $29.6M |
| Annual profit (last year) | -$20.6M |
| Net profit margin | -69.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cupertino, California |
Forecasts
